3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Ulcer
1
Stomatitis
1
Speech
1
Radiation Injuries
1
Pain
1
Mucositis
1
Head and Neck Neoplasms
1
Interventions
Cisplatin
85
pembrolizumab
76
Magnetic Resonance Spectroscopy
46
Radiotherapy, Intensity-Modulated
41
Specimen Handling
36
Cetuximab
36
Carboplatin
35
Radiotherapy
34
Nivolumab
28
Paclitaxel
24
Radiation
22
Platinum
22
Docetaxel
20
Biopsy
20
1,2-diaminocyclohexaneplatinum II citrate
20
Gemcitabine
19
Surveys and Questionnaires
15
Fluorouracil
14
toripalimab
13
Standard of Care
12
Taxes
11
cemiplimab
9
atezolizumab
9
Ipilimumab
9
Drug Therapy
9
Cyclophosphamide
9
X-Rays
8
Surgical Procedures, Operative
8
Radiosurgery
7
Immunoglobulin G
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Xylitol
×
Head & Neck
×
90 days
×
Clear all
NCT05635929
2026-04-15
STOPOMP
Mucosa Innovations, S.L.
Phase NA
Recruiting
63 enrolled